Ancora Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Ancora Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-107,685	Closed	-$5.81M	–	720
2017 Q4	$5.81M	Buy	107,685 +46,436	+76%	+$2.54M	0.31%	105
2017 Q3	$3.5M	Buy	61,249 +4,747	+8%	+$278K	0.2%	155
2017 Q2	$3.4M	Buy	56,502 +13,051	+30%	+$743K	0.22%	147
2017 Q1	$2.37M	Buy	+43,451	New	+$2.14M	0.16%	179

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Ancora Advisors's BIVV Position: Q1 2018 in Review

Ancora Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 107,685 shares — an estimated $5.81M sold.

Ancora Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $5.81M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Ancora Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Ancora Advisors sold 107,685 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5.81M.
Ancora Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Ancora Advisors's Bioverativ Inc. Common Stock position peaked at $5.81M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Ancora Advisors's 13F filing for Q1 2018, filed 15 May 2018.